Leprosy post-exposure prophylaxis risks not adequately assessed – Author's reply

Authors :: Marcos Virmond
Liesbeth Mieras
Jan Hendrik Richardus
Paul Saunderson
Eliane Ignotti
Basu Dev Pandey
Peter Steinmann
Mohammad Arif
Arielle Cavaliero
Public Health
Source :: The Lancet Global Health, 9(4), e402-e403. Elsevier
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
MEDLINE
General Medicine
medicine.disease
Leprosy
medicine
Feasibility Studies
Humans
Rifampin
Post-exposure prophylaxis
Post-Exposure Prophylaxis
Intensive care medicine
business

Tools